13F-HR filed by BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 16 holding rows worth $304,968,720.
- Accession
- 0001214659-25-016617
- Filer
- CIK 1882053
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 16 entries on the cover page, a total value of $304,968,720 stated on the cover page (in dollars after the unit check, H1), rows summing to $304,968,720 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Medtronic Plc | G5960L103 | COM | 428,789 | $40,837,864 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 535,732 | $39,274,513 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 417,833 | $27,334,635 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 82,972 | $23,916,679 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 460,282 | $23,907,047 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 166,414 | $23,361,197 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 782,461 | $20,179,669 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 58,112 | $20,066,074 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 328,546 | $17,794,051 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 95,832 | $16,770,600 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 945,042 | $13,570,803 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 715,877 | $11,718,906 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 167,932 | $8,796,278 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 147,317 | $8,598,893 | dollars as filed | |
| CLEARPOINT NEURO INC | 18507C103 | COM | 283,912 | $6,186,442 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 502,854 | $2,655,069 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-016617 | this filing | 2025-11-14 | acceptance time not in the bulk data set |